British Liver Trust Statement on the Spring Budget 2023

March 16, 2023

The British Liver Trust is delighted that our campaign, in partnership with the Alcohol Health Alliance, for alcohol duty to increase in line with inflation has been confirmed in this week’s Budget. From the 1st August most alcohol duty will increase in line with inflation.

Pamela Healy OBE, CEO of the British Liver Trust, said:

“We welcome the Chancellor’s decision to increase most alcohol duty in line with inflation from August. This is the first rise in alcohol duty in a decade and will help to save lives and reduce pressures on the NHS.

Further action is also needed to reduce alcohol harm, which is a leading driver of liver disease deaths. Alcohol specific deaths surged by 27% between 2019 and 2021, almost 80% of which were caused by alcohol related liver disease.

Liver disease deaths are also four times higher in our most deprived areas. Targeted action is needed to reduce health inequalities in liver disease, if we want to achieve the Government’s ambition to narrow the gap in Healthy Life Expectancy and level up health.”

Pricing policies and taxation are among the most effective public health measures that policymakers can use to reduce alcohol harm. Urgent action is needed around alcohol pricing and promotions, to address the burden of alcohol related liver disease on the NHS. However, today’s decision is a welcomed announcement, and will reduce alcohol harm and liver disease deaths.

More news

Our Budget Case to the Treasury: Investing in Prevention

Our Budget Case to the Treasury: Investing in Prevention

The Autumn Budget on 28th October is a chance to prevent thousands of families from experiencing the devastating impact of liver disease. Because 90% of liver disease is preventable, government action on alcohol harm and obesity could ...
Liver UK helps shape new European recommendations on liver cancer surveillance

Liver UK helps shape new European recommendations on liver cancer surveillance

A major new paper published in The Lancet Regional Health – Europe has highlighted the challenges of detecting liver cancer earlier across Europe and sets out practical lessons from countries around the world to improve surveillance ...
The LIVERAGE research studies

The LIVERAGE research studies

The LIVERAGE and LIVERAGE Cirrhosis studies are large clinical research studies for adults living with MASLD, a type of fatty liver disease. These studies focus on people with MASH, a more advanced form of MASLD.  The studies include ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.